CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 89 filers reported holding CULLINAN ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,041 | -1.1% | 24,314 | +17.6% | 0.00% | – |
| Q2 2023 | $222,506 | -2.4% | 20,679 | -7.0% | 0.00% | – |
| Q1 2023 | $228,000 | +111119.5% | 22,243 | +14.7% | 0.00% | – |
| Q4 2022 | $205 | -99.9% | 19,385 | -2.6% | 0.00% | – |
| Q3 2022 | $256,000 | +10.8% | 19,909 | +10.6% | 0.00% | – |
| Q2 2022 | $231,000 | -8.7% | 17,995 | -25.6% | 0.00% | – |
| Q1 2022 | $253,000 | -18.1% | 24,172 | +20.5% | 0.00% | – |
| Q4 2021 | $309,000 | -9.4% | 20,057 | +32.5% | 0.00% | – |
| Q3 2021 | $341,000 | +63.2% | 15,139 | +86.3% | 0.00% | – |
| Q2 2021 | $209,000 | -86.9% | 8,124 | -78.7% | 0.00% | – |
| Q1 2021 | $1,592,000 | – | 38,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |